- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Microbix Biosystems Inc. (MBX)
Microbix Biosystems Inc. stock price live, this page displays TSX MBX stock exchange data. View the MBX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Microbix Biosystems Inc. real time stock price chart below.
What Is the Microbix Biosystems Inc. Stock Price Today?
The Microbix Biosystems Inc. stock price today is 0.24.
What Is the Stock Symbol for Microbix Biosystems Inc.?
The stock symbol for Microbix Biosystems Inc. is ""MBX.""
What Stock Exchange Does Microbix Biosystems Inc. Trade On?
Microbix Biosystems Inc. is listed and trades on the Toronto stock exchange.
Is Microbix Biosystems Inc. a Good Stock to Buy?
Determining whether Microbix Biosystems Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MBX quote. (ISIN: CA59501P1045)
What Is the Microbix Biosystems Inc. Stock Price Today?
The Microbix Biosystems Inc. stock price today is 0.24.
What Is the Stock Symbol for Microbix Biosystems Inc.?
The stock symbol for Microbix Biosystems Inc. is ""MBX.""
What Stock Exchange Does Microbix Biosystems Inc. Trade On?
Microbix Biosystems Inc. is listed and trades on the Toronto stock exchange.
Is Microbix Biosystems Inc. a Good Stock to Buy?
Determining whether Microbix Biosystems Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MBX quote. (ISIN: CA59501P1045)
0.24
0.00(0.00%)
Closed·
Fair Value
An estimate of a Microbix Biosystems Inc.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.24
0.25
52 wk Range
0.22
0.55
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a Microbix Biosystems Inc.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.240.25
52 wk Range
0.220.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MBX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Microbix Biosystems Inc.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
0.50
Upside
+108.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Microbix Hosts Ontario Premier Doug Ford & Team
- Investing.com
- Microbix Reports Results for Q2 Fiscal 2025
- Investing.com
- Microbix Reports Results for Q2 Fiscal 2025
- Investing.com
- Microbix Exhibiting at ESCMID Global 2025
- Investing.com
- Microbix Hosts Ontario Premier Doug Ford & Team
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Microbix Biosystems Inc. Company Profile
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Microbix Biosystems Inc. Earnings Call Summary for Q3/2025
- Q3 Fiscal 2025 weakest in 3 years; net loss of $77.02M in last 12 months due to major client slowdowns
- Stock dropped 14.29% to 0.24 post-earnings; negative EBITDA of $86.28M indicates overvaluation
- YTD growth in caps (13%) and antigen (34%) businesses, excluding affected clients
- Focus on H5N1 and COVID testing products; Kinlytic launch targeted for 2027
- Recovery expected in fiscal 2026 with potential sales growth from five major clients
Last Updated: 14/08/2025, 15:58
Read Full TranscriptCompare MBX to Peers and Sector
Metrics to compare | MBX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMBXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −107.2x | −4.1x | −0.6x | |
PEG Ratio | 1.01 | 0.02 | 0.00 | |
Price/Book | 1.2x | −0.3x | 2.6x | |
Price / LTM Sales | 1.6x | 8.7x | 3.3x | |
Upside (Analyst Target) | 100.0% | 142.0% | 41.4% | |
Fair Value Upside | Unlock | −5.8% | 6.0% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.50
(+108.33% Upside)
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
3.47M / 4.90M
FAQ
What Stock Exchange Does Microbix Biosystems Inc. Trade On?
Microbix Biosystems Inc. is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Microbix Biosystems Inc.?
The stock symbol for Microbix Biosystems Inc. is "MBX."
What Is the Microbix Biosystems Inc. Market Cap?
As of today, Microbix Biosystems Inc. market cap is 33.42M.
What Is Microbix Biosystems Inc.'s Earnings Per Share (TTM)?
The Microbix Biosystems Inc. EPS (TTM) is -0.00.
When Is the Next Microbix Biosystems Inc. Earnings Date?
Microbix Biosystems Inc. will release its next earnings report on 17 Dec 2025.
From a Technical Analysis Perspective, Is MBX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Microbix Biosystems Inc. Stock Split?
Microbix Biosystems Inc. has split 0 times.
How Many Employees Does Microbix Biosystems Inc. Have?
Microbix Biosystems Inc. has 100 employees.
What is the current trading status of Microbix Biosystems Inc. (MBX)?
As of 04 Dec 2025, Microbix Biosystems Inc. (MBX) is trading at a price of 0.24, with a previous close of 0.24. The stock has fluctuated within a day range of 0.24 to 0.25, while its 52-week range spans from 0.22 to 0.55.
What Is Microbix Biosystems Inc. (MBX) Price Target According to Analysts?
The average 12-month price target for Microbix Biosystems Inc. is CAD0.5, with a high estimate of CAD0.5 and a low estimate of CAD0.5. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +108.33% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.